Terris Tang

Hong Kong
  • 18th Floor, One Exchange Square
  • 8 Connaught Place, Central
  • Hong Kong
 
 

Terris Tang is a partner in the Hong Kong office of Latham & Watkins and a member of the Corporate Department.

Mr. Tang advises clients on various corporate finance transactions, including:

  • Capital markets, including initial public offerings
  • Mergers and acquisitions
  • Corporate restructurings
  • Private equity
  • General compliance matters

Mr. Tang has more than 15 years of experience advising PRC and international corporations, private equity firms, and financial institutions on their capital markets transactions and investments across Asia and globally.

Mr. Tang advises on a broad range of business sectors, including energy and mining, financial services, real estate, technology, media, and telecommunications.

Mr. Tang's experience includes advising:

Capital Markets

  • The underwriters in the secondary listing and US$1.07 billion initial public offering of Trip.com, a leading one-stop travel platform globally, on the Main Board of The Stock Exchange of Hong Kong Limited
  • The underwriters on the HK$1.824 billion initial public offering of H shares on the Main Board of the Hong Kong Stock Exchange for Suzhou Basecare Medical, the leading innovative platform of genetic testing solutions for assisted reproduction in China
  • Kuaishou Technology, a leading content community and social platform globally, on its US$5.4 billion initial public offering and listing on the Main Board of the Hong Kong Stock Exchange
  • Fulu Holdings, China’s largest third-party virtual service provider, on its US$115 million IPO of shares on the Main Board of Hong Kong Stock Exchange
  • The underwriters on the HK$2.1 billion initial public offering and listing of Alphamab Oncology, a leading biopharmaceutical company dedicated to global development of innovative biologics for cancer therapy, on the Main Board of The Stock Exchange of Hong Kong
  • ESR Cayman Limited on the US$1.5 billion initial public offering and listing on the Main Board of Hong Kong Stock Exchange, the third largest IPO in Hong Kong in 2019 and the largest RE IPO in ten years
  • China Risun Group Limited on its HK$1.7 billion initial public offering and listing on the Main Board of Hong Kong Stock Exchange; China Risun Group is a world leading independent producer and supplier of coke and coking chemicals
  • The Singapore-headquartered data centre provider ST Telemedia Global Data Centres as the shareholder in the secondary listing of GDS Holdings Limited, the leading high performance carrier-neutral data center solution provider in China, on the Main Board of Hong Kong Stock Exchange
  • Juno Therapeutics (a Bristol Myers Squibb Company), an integrated biopharmaceutical company focusing on developing cellular immunotherapies for the treatment of cancer, as the largest shareholder in the initial public offering of JW (Cayman) Therapeutics Co. Ltd, a leading clinical and pre-clinical stage cell therapy company in China, on the Main Board of Hong Kong Stock Exchange
  • The underwriters on the HK$5.46 billion initial public offering and listing of Guizhou Bank on the Main Board of The Stock Exchange of Hong Kong
  • The underwriters on the HK$2.59 billion initial public offering and listing of Venus MedTech (HangZhou) Inc. on the Main Board of The Stock Exchange of Hong Kong
  • Sinochem Hong Kong (Group) and China Jinmao Holdings Group on a placing of existing shares and issuance of new shares, respectively, with a total transaction size of HK$9.49 billion
  • The underwriters on the HK$9.1 billion H-share initial public offering of Shenwan Hongyuan Group on the Main Board of the Hong Kong Stock Exchange
  • The joint sponsors and underwriters on Jiangxi Bank’s HK$7.48 billion initial public offering of H Shares on the Main Board of The Stock Exchange of Hong Kong
  • China Traditional Chinese Medicine Holdings on the placement of 604.3 million shares to Ping An Life Insurance Company of China for HK$2.68 billion
  • Bank of Gansu on its HK$6 billion initial public offering of H shares on the Main Board of Hong Kong Stock Exchange, becoming the first listed bank in Northwest China
  • China Jinmao Holdings Group on its HK$3.33 billion placing of existing shares and top-up subscription of new shares
  • Kunming Dianchi Water Treatment Company, Yunnan’s largest wastewater treatment and reclaimed water supplier, on its HK$1.41 billion initial public offering of H shares on the Hong Kong Stock Exchange
  • Yuk Wing Group Holdings on its initial public offering on the Hong Kong Stock Exchange
  • JPMorgan, Goldman Sachs, and UBS as underwriters on the US$748 million initial public offering and listing of HKBN on the Hong Kong Stock Exchange
  • Kinetic Mines and Energy, an integrated coal provider operating in China, on its initial public offering of 930 million shares and listing on the Hong Kong Stock Exchange, including its international offering (144A/Reg S) of 837 million shares and Hong Kong public offering of 93 million shares
  • The underwriters on Bank of China’s initial public offering and listing on the Hong Kong Stock Exchange*

M&A

  • Aspex Management on its Series E investment as lead investor into Klook, an online travel activities and services booking platform company
  • Everbright Securities on the purchase of 30% shares of Sun Hung Kai Financial Group Limited held by Sun Hung Kai & Co. Limited
  • Huarong Investment Stock Corporation Limited, a Hong Kong listed company, on its privatization by way of scheme of arrangement by Huarong International Financial Holdings Limited
  • Bilibili in its strategic investment in Huanxi Media, a company principally engaged in media- and entertainment-related businesses
  • China Jinmao as the offeror on the privatization of Jinmao Hotel and Jinmao (China) Hotel Investments and Management Limited — the first-ever privatization of a Hong Kong listed business trust
  • Yuk Wing Group Holdings Limited on a mandatory unconditional cash offer for the outstanding shares in the company triggered by the sale of a 51.32% stake by its controlling shareholder
  • China Merchants & Great Wall Ocean Strategy & Technology Fund (L.P.) on its HK$512.7 million investment to acquire 51.97% interests in TSC Group Holdings Limited
  • HKBN on its approximately US$1.3 billion acquisition of WTT Holding, a Hong Kong-based fixed telecommunication services operator
  • China Life Investment Holding on its £795 million acquisition of a majority stake in 10 Upper Bank Street, Canary Wharf, London, which is one of Britain’s biggest office towers, representing the first European property investment by China Life
  • China Life Insurance (Overseas) on its acquisition of a minority interest in JD.com, a provider of online shopping services, from an existing shareholder
  • PPTV, an online video business in China and its selling shareholders on its sale of 100% of PPTV’s shares held by the existing shareholders valued at US$420 million, to Suning Commerce Group, a domestically listed conglomerate, and Hony Capital, a private equity fund associated with Legend Holding
  • Sinochem International (Overseas) on its acquisition of a 40% equity stake in Jiangsu Sinorgchem Technology the world’s leading rubber additive producer and technical developer
  • Hong Kong Television Network Limited (formerly known as City Telecom (HK) Limited) (CTI) on its HK$5 billion sale of Hong Kong Broadband Network (HKBN) and IDD businesses to Metropolitan Light Company, a company formed by CVC Funds

*Matter handled prior to joining Latham

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.